Pharmaceutical Product Development Inc. (PPDI) reported that its fourth-quarter net income decreased to $18.991 million or $0.16 per share from $47.200 million or $0.40 per share last year.
On average, 11 analysts polled by Thomson Reuters expected the company to report profit of $0.23 per share for the quarter. Analysts' estimates typically exclude special items.
Total net revenue decreased to $357.402 million from $363.139 million a year ago. Analysts expected revenue of $314.33 million for the quarter.
For comments and feedback: editorial@rttnews.com